Evolus, Inc. Common Stock (EOLS)
Evolus, Inc. (EOLS) is a medical aesthetics company specializing in products for facial aesthetic procedures. The company is best known for its flagship product, Jeuveau, a neurotoxin used to temporarily improve the appearance of fine lines and wrinkles. Evolus focuses on providing innovative solutions for practitioners and patients seeking non-invasive cosmetic treatments.
Company News
The article discusses the debut of Chinese boba tea chain Mixue on the Hong Kong stock exchange, the departure of Kroger's CEO due to personal conduct issues, and Domino's introduction of stuffed crust pizza. It also covers the booming med spa industry and the performance of Evolus, a competitor to Botox.
In our monthly Rare Stock Picks series, we're highlighting May 2024 investment picks. Click here for the list of May 2024 Buy recommendations.
The addition of Evolysse fillers to the company's portfolio complements Evolus' (EOLS) flagship neurotoxin Jeuveau.
Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped...
They have a kind of staying power that’s more akin to a staple than a discretionary purchase for many of their users.